ArticleACS omega2025
Environmentally Safe Synthesis of Gold Nanoparticles for Antigen Detection in CLIA System.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of gold nanoparticles (AuNPs) has been explored in the last decades, and most recently, efforts have been made to associate their production with environmentally safe routes and biotechnological processes. The versatility of bioconjugation strategies used for AuNPs makes them a promising tool for developing alternative detection methods for traditional diagnostic assays. In this work, we present a chemiluminescent immunoassay based on AuNPs for specific and sensitive detection of SARS-CoV-2. The AuNPs were processed through a physical route, deposited on a solid substrate via magnetron sputtering, and functionalized with anti-SARS-CoV-2 antibodies. The colloidal stability of the AuNPs was monitored through UV-vis spectroscopy and transmission electron microscopy (TEM). UV-vis showed a plasmon resonance peak at ∼535 nm, consistent with the TEM results, which presented an average size of the AuNP around 40 nm. Altogether, nasopharyngeal swabs of 180 patients were tested with the antibody-AuNP bioconjugates to recognize their corresponding antigens through chemiluminescent immunoassays (CLIA). To assess the affinity and specificity of the functionalized AuNPs, comparative experiments of CLIA and classical enzyme-linked immunosorbent assay (ELISA) were conducted. CLIA results outperformed ELISA and were effective in detecting SARS-CoV-2-positive samples with a viral load exceeding 1.19 ng/mL. Analysis of the Receiver Operating Characteristic curve yielded an AUROC of 0.909 (95% CI: 0.864-0.955), indicating excellent discriminative ability, with a sensitivity of 91% and a specificity of 85%. The results provided new insights into AuNPs produced by an environmentally safe synthesis with excellent functionalization and detection capability for diagnostic applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.